| SP1 | Coordination and central infrastructure of the TreatHSP.net consortium | Rebecca Schüle (University of Tübingen) |
| SP2 | Sensor-based monitoring of gait in HSP patients and implementation in everyday life | Zacharias Kohl, Jürgen Winkler (Universitätsklinikum Erlangen) |
| SP3 | Development and validation of patient- and caregiver-reported outcome parameters in HSP | Stephan Klebe, Karl-Heinz Jöckel (University Hospital Essen) |
| SP4 | Biomarker development and identification of new therapeutic targets for SPG 4 and SPG31 in neuronal model systems | Ludger Schöls, Stefan Hauser (University oTübingen) |
| SP5 | Metabolomic investigations in selected mouse models for hereditary spastic paraplegia (HSP) | Christian Hübner (University of Jena) |
| SP6 | The 'diagnostic gap' in HSP - non-coding variants in known HSP genes | Rebecca Schüle, Stefan Ossowski (University of Tübingen) |
| SP7 | GSK3ß dependent mechanisms in neurons derived from human stem cells for autosomal recessive HSP | Beate Winner, Martin Regensburger (Universitätsklinikum Erlangen) |
| SP8 | Pathogenic mechanisms and therapeutic approaches for HSP caused by mutations in SPG7 | Elena Rugarli (University of Cologne) |
| SP9 | Inflammation as a possible target in the treatment of SPG11: repurposing of clinically established immunomodulators for the treatment of a genetic disease of the nervous system | Rudolf Martini, Janos Groh (University of Würzburg) |
